research use only

S5a/PSMD4 Antibody [K9M17]

Catalog No.: F5083

    Application: Reactivity:
    • F5083-wb
      Lane 1: MCF7, Lane 2: Neuro-2a, Lane 3: H-4-II-E, Lane 4: COS7

    Usage Information

    Dilution
    1:1000
    1:100
    Application
    WB, IP
    Reactivity
    Human, Mouse, Rat, Monkey
    Source
    Mouse Monoclonal Antibody
    Storage Buffer
    PBS, pH 7.2+50% Glycerol+0.05% BSA+0.01% NaN3
    Storage (from the date of receipt)
    -20°C (avoid freeze-thaw cycles), 2 years
    Predicted MW
    50 kDa
    Positive Control A172 cell; MCF7 cell; DU 145 cell; NCI-H23 cell; Hep G2 cell; Neuro-2a cell; NIH/3T3 cell; H-4-II-E cell; COS-7 cell
    Negative Control

    Exprimental Methods

    WB
    Experimental Protocol:
     
    Sample preparation
    1. Tissue: Lyse the tissue sample by adding an appropriate volume of ice-cold RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail),and homogenize the tissue at a low temperature.
    2. Adherent cell: Aspirate the culture medium and wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    3. Suspension cell: Transfer the culture medium to a pre-cooled centrifuge tube. Centrifuge and aspirate the supernatant. Wash the cells with ice-cold PBS twice. Lyse the cells by adding an appropriate volume of RIPA/NP-40 Lysis Buffer (containing Protease Inhibitor Cocktail) and put the sample on ice for 5 min.
    4. Place the lysate into a pre-cooled microcentrifuge tube. Centrifuge at 4°C for 15 min. Collect the supernatant;
    5. Remove a small volume of lysate to determine the protein concentration;
    6. Combine the lysate with protein loading buffer. Boil 20 µL sample under 95-100°C for 5 min. Centrifuge for 5 min after cool down on ice.
     
    Electrophoretic separation
    1. According to the concentration of extracted protein, load appropriate amount of protein sample and marker onto SDS-PAGE gels for electrophoresis. Recommended separating gel (lower gel) concentration: 10%. Reference Table for Selecting SDS-PAGE Separation Gel Concentrations
    2. Power up 80V for 30 minutes. Then the power supply is adjusted (110 V~150 V), the Marker is observed, and the electrophoresis can be stopped when the indicator band of the predyed protein Marker where the protein is located is properly separated. (Note that the current should not be too large when electrophoresis, too large current (more than 150 mA) will cause the temperature to rise, affecting the result of running glue. If high currents cannot be avoided, an ice bath can be used to cool the bath.)
     
    Transfer membrane
    1. Take out the converter, soak the clip and consumables in the pre-cooled converter;
    2. Activate PVDF membrane with methanol for 1 min and rinse with transfer buffer;
    3. Install it in the order of "black edge of clip - sponge - filter paper - filter paper - glue -PVDF membrane - filter paper - filter paper - sponge - white edge of clip";
    4. The protein was electrotransferred to PVDF membrane. ( 0.45 µm PVDF membrane is recommended ) Reference Table for Selecting PVDF Membrane Pore Size Specifications
    Recommended conditions for wet transfer: 200 mA, 120 min.
    ( Note that the transfer conditions can be adjusted according to the protein size. For high-molecular-weight proteins, a higher current and longer transfer time are recommended. However, ensure that the transfer tank remains at a low temperature to prevent gel melting.)
     
    Block
    1. After electrotransfer, wash the film with TBST at room temperature for 5 minutes;
    2. Incubate the film in the blocking solution for 1 hour at room temperature;
    3. Wash the film with TBST for 3 times, 5 minutes each time.
     
    Antibody incubation
    1. Use 5% skim milk powder to prepare the primary antibody working liquid (recommended dilution ratio for primary antibody 1:1000), gently shake and incubate with the film at 4°C overnight;
    2. Wash the film with TBST 3 times, 5 minutes each time;
    3. Add the secondary antibody to the blocking solution and incubate with the film gently at room temperature for 1 hour;
    4. After incubation, wash the film with TBST 3 times for 5 minutes each time.
     
    Antibody staining
    1. Add the prepared ECL luminescent substrate (or select other color developing substrate according to the second antibody) and mix evenly;
    2. Incubate with the film for 1 minute, remove excess substrate (keep the film moist), wrap with plastic film, and expose in the imaging system.

    Datasheet & SDS

    Biological Description

    Specificity
    S5a/PSMD4 Antibody [K9M17] detects endogenous levels of total S5a/PSMD4 protein.
    Subcellular Location
    Proteasome
    Uniprot ID
    P55036
    Clone
    K9M17
    Synonym(s)
    26S proteasome non-ATPase regulatory subunit 4; 26S proteasome regulatory subunit RPN10; 26S proteasome regulatory subunit S5A; Antisecretory factor 1 (AF; ASF); Multiubiquitin chain-binding protein; PSMD4; MCB1
    Background
    S5a, also known as PSMD4 or Rpn10, is a non-ATPase subunit of the 19S regulatory particle of the 26S proteasome complex and plays a central role in the ubiquitin-proteasome system responsible for targeted protein degradation. S5a contains two polyubiquitin-interacting motifs (UIMs) that mediate high-affinity binding to polyubiquitin chains via hydrophobic interactions, as well as a von Willebrand factor type A (VWA) domain that facilitates proteasome integration and regulates UIM accessibility. S5a acts as a ubiquitin receptor, recognizing and recruiting ubiquitinated substrates to the proteasome for degradation, thus maintaining protein homeostasis and regulating processes such as cell cycle progression, signal transduction, and stress responses. It also binds ubiquitin-like (UBL) domains present in shuttle proteins, facilitating efficient substrate delivery to the proteasome. S5a modulates the ubiquitin-proteasome pathway and regulates the degradation of key proteins, including transcription factors like ATF4 and cell cycle inhibitors, thereby influencing pathways such as NF-κB signaling. Dysregulation of S5a or associated ubiquitin receptors is implicated in cancer and neurodegenerative diseases due to the accumulation of misfolded or damaged proteins.
    References
    • https://pubmed.ncbi.nlm.nih.gov/19240029/
    • https://pubmed.ncbi.nlm.nih.gov/25318673/

    Tech Support

    Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

    Handling Instructions

    Tel: +1-832-582-8158 Ext:3
    If you have any other enquiries, please leave a message.

    * Indicates a Required Field

    Please enter your name.
    Please enter your email. Please enter a valid email address.
    Please write something to us.